The NVAC currently has no active subcommittees, choosing rather to address topical issues through working groups. The initial charges and outputs/products of the subcommittees are listed below.
Subcommittee on Vaccine Development & Supply
The Subcommittee will consider policy options and inform NVAC discussions and recommendations regarding the development, licensure, and best use of new and existing vaccines including: new or improved vaccines for infectious and non-infectious conditions; vaccines using new technologies; and new approaches to vaccine delivery. The Subcommittee will identify research needs and priorities related to these aspects of vaccine development. The Subcommittee will also consider policy options and inform NVAC discussions and recommendations regarding the development and maintenance of an adequate and secure supply of recommended vaccines.
Subcommittee on Safety Charge
The Subcommittee will consider policy options and inform NVAC discussions and recommendations regarding vaccine safety issues. In addition, the Subcommittee will review priorities relating to the safety of vaccines and immunization and report regularly to NVAC and the Department on the progress of such priorities.
Subcommittee on Communication & Public Engagement
The Subcommittee will consider and inform the NVAC discussions and recommendations regarding methods that will effectively communicate the benefits and risks of vaccines to the public, policymakers, and key stakeholders and provide effective opportunities for ongoing dialogue with the public on vaccine and immunization issues.
Subcommittee on Immunization Coverage
The Subcommittee will consider policy options and inform NVAC discussions and recommendations regarding improvements in immunization coverage levels, including issues related to the financing of vaccines, for infants, children, adolescents, and adults.